Match!
Cheng-Tao Chang
Allergan
6Publications
1H-index
7Citations
Publications 6
Newest
1 CitationsSource
1 CitationsSource
1 CitationsSource
Abstract Treatment-emergent suicidal ideation and behavior are ongoing concerns with antidepressants. Vilazodone, currently approved for the treatment of major depressive disorder (MDD) in adults, has also been evaluated in generalized anxiety disorder (GAD). Post-hoc analyses of vilazodone trials were carried out to examine its effects on suicidal ideation and behavior in adults with MDD or GAD. Data were pooled from vilazodone trials in MDD (four studies) and GAD (three studies). The incidence...
4 CitationsSource
#2John M. KaneH-Index: 105
Last.Willie EarleyH-Index: 12
view all 7 authors...
Abstract Background: Relapse is common in schizophrenia; identifying characteristics associated with relapse may help improve disease management. Cariprazine, a D3/D2 receptor partial agonist, is approved in the United States for the treatment of schizophrenia. Post hoc analyses of a long-term, randomized, double-blind (up to 72 weeks), relapse prevention trial (NCT01412060) were performed to identify characteristics associated with relapse in placebo- and cariprazine-treated patients. Methods: ...
Source
#1Steven G. Potkin (UCI: University of California, Irvine)H-Index: 83
Last.Willie Earley (Allergan)H-Index: 2
view all 6 authors...
Source
1